<SEC-DOCUMENT>0001093557-20-000177.txt : 20200601
<SEC-HEADER>0001093557-20-000177.hdr.sgml : 20200601
<ACCEPTANCE-DATETIME>20200601165130
ACCESSION NUMBER:		0001093557-20-000177
CONFORMED SUBMISSION TYPE:	SD
PUBLIC DOCUMENT COUNT:		3
<RULE>
<RULE-NAME>13p-1
<ITEM>
<ITEM-NUMBER>1.01
<ITEM-PERIOD>20191231
</ITEM>
<ITEM>
<ITEM-NUMBER>1.02
<ITEM-PERIOD>20191231
</ITEM>
</RULE>
FILED AS OF DATE:		20200601
DATE AS OF CHANGE:		20200601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SD
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		20934004

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>SD
<SEQUENCE>1
<FILENAME>a2020formsd.htm
<DESCRIPTION>SD
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s84F6A82015C25F9AAAEA51FAAB5F9DCD"></a></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">FORM SD</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SPECIALIZED DISCLOSURE REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;"><img src="dexcomgreenstandalone.jpg" alt="dexcomgreenstandalone.jpg" style="height:28px;width:190px;"></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">DEXCOM, INC. </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in its Charter) </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:84px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.65811965811966%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Delaware</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">000-51222</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">33-0857544</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation or organization )</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">6340 Sequence Drive, San Diego, California&#160;&#160;&#160;&#160;92121</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;                                                                   (Zip Code)</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Patrick M. Murphy</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(858) 200-0200</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Name and telephone number, including area code, of the person to contact in connection with this report.)</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Not Applicable</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report) </font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;<br>Check the appropriate box below to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:</font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;</font><font style="font-family:Wingdings;font-size:12pt;">x</font></div></td><td style="vertical-align:top;padding-left:12px;"><div style="line-height:130%;text-align:justify;font-size:12pt;text-indent:-12px;"><font style="font-family:inherit;font-size:10pt;">&#32;Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period January 1 to December 31, 2019</font></div></td></tr></table><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:130%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div><br></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Item 1.01.   Conflict Minerals Disclosure and Report.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Conflict Minerals Disclosure</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A copy of the Conflict Minerals Report of DexCom, Inc. (&#8220;DexCom&#8221;) for the reporting period January 1 to December 31, 2019 is filed as Exhibit 1.01 to this specialized disclosure report on Form SD and is also available at DexCom&#8217;s website at https://investors.dexcom.com/sec-filings.  </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Item 1.02.   Exhibit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DexCom has filed, as an exhibit to this Form SD, a Conflict Minerals Report as required by Item 1.01 of this Form.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.50427350427351%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:14%;"></td><td style="width:6%;"></td><td style="width:80%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit <br>Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Description of Document</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:12pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex101conflictmineralsrepor.htm"><font style="font-family:inherit;font-size:12pt;">1.01</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex101conflictmineralsrepor.htm"><font style="font-family:inherit;font-size:12pt;">DexCom, Inc. Conflict Minerals Report for the reporting period January 1 to December 31, 2019.</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.86324786324786%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:9%;"></td><td style="width:58%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:16px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DEXCOM, INC.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dated:  June 1, 2020</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Patrick M. Murphy_____________</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Patrick M. Murphy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Executive Vice President and Chief Legal Officer</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:144px;text-indent:-96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.01
<SEQUENCE>2
<FILENAME>ex101conflictmineralsrepor.htm
<DESCRIPTION>EXHIBIT 1.01
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s7A9883C6E7DF5D669612F9060DC24B06"></a></div><div style="line-height:120%;padding-top:16px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 1.01 to Form SD</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conflict Minerals Report</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Reporting Period January 1 to </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Conflict Minerals Report (&#8220;CMR&#8221;) has been prepared by DexCom, Inc. (herein referred to, alternatively, as &#8220;DexCom,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221;).  This CMR for the reporting period January 1 to </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;is presented to comply with the final conflict minerals implementing rules (&#8220;Final Rules&#8221;) promulgated by the Securities and Exchange Commission (&#8220;SEC&#8221;), as modified by SEC guidance issued on April 29, 2014 and the SEC order issued on May 2, 2014. The Final Rules were adopted by the SEC to implement reporting and disclosure requirements related to conflict minerals as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 as codified in Section 13(p) of the Securities Exchange Act of 1934.  The Final Rules impose certain reporting obligations on SEC registrants whose manufactured products contain conflict minerals that are necessary to the functionality or production of their products. &#8220;Conflict minerals&#8221; are currently defined by the SEC as cassiterite, columbite-tantalite (coltan), gold, wolframite, or their derivatives, which the SEC has currently limited to tin, tantalum, and tungsten.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To comply with the Final Rules, we conducted due diligence on the origin, source and chain of custody of the conflict minerals that were necessary to the functionality or production of the products that we manufactured or contracted to manufacture to ascertain whether these conflict minerals originated in the Democratic Republic of the Congo or an adjoining country (collectively, &#8220;Covered Countries&#8221;) and financed or benefited armed groups (as defined in Section 1, Item 1.01(d)(2) of Form SD) in any of these countries.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to SEC guidance issued April 29, 2014 and the SEC order issued May 2, 2014, DexCom is not required to describe any of its products as&#160;&#8220;DRC conflict free&#8221; (as defined in Section 1, Item 1.01(d)(4) of Form SD), &#8220;DRC conflict undeterminable&#8221; (as defined in Section 1, Item 1.01(d)(5) of Form SD) or &#8220;having not been found to be &#8216;DRC conflict free,&#8217;&#8221; and therefore makes no conclusion in this regard in the report presented herein.&#160; Furthermore, given that DexCom has not voluntarily elected to describe any of its products as &#8220;DRC conflict free,&#8221; an independent private sector audit of the report presented herein has not been conducted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">I.    Company Overview</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the United States (U.S.) Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the DexCom G6</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">II.   Product Overview</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G6</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2018, we obtained marketing authorization from the FDA for the G6 via the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">de novo</font><font style="font-family:inherit;font-size:10pt;">&#32;process. The G6 is the first type of CGM system permitted by the FDA to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. G6 and substantially equivalent devices of this generic type that may later receive marketing authorization are referred to as integrated continuous glucose monitoring systems, or iCGMs, and have been classified as Class II devices by the FDA. Along with this classification, the FDA established criteria, called special controls, which outline requirements for assuring CGM accuracy, reliability and clinical relevance, and which also describe the type of studies and data required to demonstrate acceptable CGM performance. The G6 is designed to allow our transmitter to run an algorithm to </font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:624px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">generate a glucose value and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, iPod touch</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, iPad</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, and certain Android</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;mobile devices. A patient&#8217;s glucose data can also be displayed on wearable devices, like the Apple Watch</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;and Wear OS by Google devices. The G6 transmitter has a labeled useful life of three months. Data from the G6 can be integrated with DexCom CLARITY</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, our cloud-based reporting software, for personalized, easy-to-understand analysis of trends that may improve diabetes management. In the United States, the G6 is covered by Medicare as well as those commercial insurers that reimburse for the DexCom G5 Mobile Continuous Glucose Monitoring System, subject to satisfaction of certain eligibility and coverage criteria. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2018, we received Conformit&#233; Europ&#233;enne Marking, or CE Mark, approval for the G6, which allows us to market the system in the European Union and the countries in Asia and Latin America that recognize the CE Mark, as well as New Zealand, though certain countries may require compliance with certain local administrative requirements and/or additional marketing authorizations (for example, the inclusion of medical devices on the Australian Register of Therapeutic Goods in Australia).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2019, we also received marketing authorization from the FDA for the DexCom G6 Pro, or G6 Pro, which allows healthcare professionals to purchase the G6 for use with their patients. The G6 Pro has many of same features as the G6 and is intended for healthcare professionals to use with their patients ages two years and up. The G6 Pro may be used in a blinded or unblinded mode for up to 10 days.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the G6, the sensor is inserted by the user and is intended to be used continuously for up to 10 days, after which it may be replaced with a new disposable sensor. Our transmitter is reusable until it reaches the end of its use life. Our receiver is also reusable. As we establish an installed base of customers using our products, we expect to generate an increasing portion of our revenues through recurring sales of our disposable sensors.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The G6 carries forward important features of prior generation DexCom CGM systems:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Continuous glucose readings.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Automatically sends glucose readings to a DexCom receiver or compatible mobile device every five minutes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Mobile app and sharing.</font><font style="font-family:inherit;font-size:10pt;">&#32;Compatibility with mobile device applications allows for sharing glucose information with other people for added support and care coordination.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Customizable alarms and alerts.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Personalized alert schedule immediately warns the user of pending dangerous high and low blood sugars.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The G6 also has a number of new or improved features compared to our prior generation devices:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Finger stick elimination.</font><font style="font-family:inherit;font-size:10pt;">&#32;No finger sticks are needed for calibration or diabetes treatment decisions, consistent with the instructions for use.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Easy sensor application.</font><font style="font-family:inherit;font-size:10pt;">&#32;Complete redesign of the sensor applicator allows for one-touch, simple self-insertion.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Discreet and low profile.</font><font style="font-family:inherit;font-size:10pt;">&#32;A redesigned transmitter with a 28% lower profile than the previous generation DexCom CGM system makes the device comfortable and easy to wear under clothing.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Medication blocking.</font><font style="font-family:inherit;font-size:10pt;">&#32;New feature allows for more accurate glucose readings without interference from common medications taken at typical indication doses, such as acetaminophen.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Predictive low alert.</font><font style="font-family:inherit;font-size:10pt;">&#32;New alert feature intended to predict hypoglycemia before it hits to help avoid dangerous low blood sugar events.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Extended 10-day sensor.</font><font style="font-family:inherit;font-size:10pt;">&#32;Up to 10-day sensor use allows for 43% longer wear than previous generation DexCom CGM systems.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other than with respect to the foregoing, the G6 is equivalent to our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications of, or revisions to, the device may be made under the 510(k) process.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G5</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Mobile</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2015, we received approval from the FDA for the DexCom G5 Mobile Continuous Glucose Monitoring System, also referred to as the G5 Mobile. The G5 Mobile is designed to allow our transmitter to run the Software 505 algorithm, and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone, iPod touch, iPad, and certain Android mobile devices. The G5 Mobile transmitter has a labeled useful life of three </font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;2&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">months. Data from the G5 Mobile can be integrated with DexCom CLARITY. In September 2015, we launched the G5 Mobile in certain countries in Europe.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Similar to the G6, the disposable sensor is inserted by the user and is intended to be used continuously for up to seven days, after which it may be replaced with a new sensor. The related transmitter is reusable until it reaches the end of its use life, and the related receiver is also reusable. In December 2016, the </font><font style="font-family:inherit;font-size:10pt;">FDA</font><font style="font-family:inherit;font-size:10pt;">&#32;approved the G5 Mobile as the first CGM system in the United States to have a non-adjunctive indication. The non-adjunctive indication expands the lawfully permitted use of the G5 Mobile as a replacement to finger stick glucose testing for diabetes treatment decisions. With the new label indication, the G5 Mobile only requires two finger sticks per day for calibration. In the countries and regions outside of the United States that recognize the CE Mark, as well as the United States and Canada, the G5 Mobile also does not require confirmatory finger sticks when making treatment decisions, although a minimum of two finger sticks a day remain necessary for calibration. Approval of the non-adjunctive indication was also an important and necessary step in enabling people with Medicare to access CGM. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except with respect to the foregoing, the G5 Mobile is functionally equivalent to our earlier generation CGM systems in its technical capabilities and its regulatory requirements and indications.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom G4</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;PLATINUM</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The DexCom G4 PLATINUM CGM system, or G4 PLATINUM, replaced our DexCom SEVEN PLUS system beginning in 2012, when it was approved for up to seven days of continuous use by adults with diabetes. Since 2012, we have marketed the G4 PLATINUM under a CE Mark in the European Union, the countries in Asia and Latin America that recognize the CE Mark, New Zealand and Australia, and in the United States with approval from the FDA. We received approvals for a pediatric indication under the CE Mark in February 2013 and from the FDA in February 2014, enabling us to market and sell this system to persons two years old and older who have diabetes. In June 2014, we received approval from the FDA for an expanded indication for the G4 PLATINUM for professional use, which allows healthcare professionals to purchase the G4 PLATINUM system for use with multiple patients. Healthcare professionals can use the insights gained from a G4 PLATINUM professional session to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress and medications have on their glucose levels. In October 2014, we launched our Software 505 algorithm for the G4 PLATINUM, an algorithm which enabled our systems to achieve a single digit MARD, a measure of the accuracy of continuous glucose monitoring. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DexCom Share</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2015, we received approval from the FDA for the G4 PLATINUM with DexCom Share, or Share, and began commercializing this product in the United States in the first quarter of 2015 using a secure wireless connection between a patient&#8217;s G4 PLATINUM receiver and an app. We now offer this feature through the G6 and the G5 Mobile apps as well as the Share2 app, which works with the G4 PLATINUM receiver with Share. The Share remote monitoring system uses an app on the patient&#8217;s iPhone, iPod touch, iPad or Android mobile device to transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, or &#8220;followers,&#8221; who can remotely monitor a patient&#8217;s glucose information and receive alert notifications anywhere they have an Internet or cellular connection. A patient&#8217;s glucose data can also be displayed on a patient&#8217;s or follower&#8217;s wearable device, such as the Apple Watch and Wear OS by Google devices, when used in conjunction with the patient&#8217;s or follower&#8217;s iPhone or Android mobile device.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Data and Insulin Delivery Collaborations</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have entered into multiple collaboration agreements that leverage our technology platform to integrate our CGM products with insulin delivery systems. The general purpose of these development and commercial relationships is to integrate our technology into the insulin pump or pen product offerings of the respective partner, enabling the partner&#8217;s insulin delivery device to receive and display glucose readings from our transmitter and, in some cases, use the glucose readings for semi-automated insulin delivery. Currently, we have announced significant insulin delivery partnerships with Eli Lilly, Insulet, Novo Nordisk and Tandem Diabetes. In addition to these major partners, we are working with other companies that are pursuing varying strategies surrounding semi-automated insulin delivery and data analytics to improve outcomes and ease-of-use in diabetes management. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Verily Collaboration</font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;3&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily from August 2015, as amended in October 2016, and eliminated any future royalty obligations under the original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily have agreed to continue to jointly develop a certain next-generation CGM product, and potentially one or more additional CGM products, for which we will have exclusive commercialization rights. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture, and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. The Restated Collaboration Agreement requires us to use commercially reasonable efforts to develop, launch, and commercialize the CGM product(s) that are the subject of the collaboration according to certain timing and other objectives, and provides for one executive sponsor from each of us and Verily to meet periodically and make decisions related to the collaboration (within a limited scope of authority) by consensus.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we have made upfront and incentive payments, and will make potential future milestone payments upon the achievement of certain goals, as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 28, 2018, we made an initial payment of $250.0 million in shares of our common stock, calculated under the Restated Collaboration Agreement to be 1,840,943 shares of our common stock, allocated between Verily and Onduo, LLC, subject to certain transfer restrictions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During 2019, we paid </font><font style="font-family:inherit;font-size:10pt;">$3.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the completion of certain development obligations before the agreed-upon deadline.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional milestone payments of up to </font><font style="font-family:inherit;font-size:10pt;">$275.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;may become due and payable by us upon the achievement of future product regulatory approval and revenue milestones. At our election, we may make these milestone payments in shares of our common stock, also allocated between Verily and Onduo, LLC, with the number of shares being calculated based on the same share value that was used for purposes of the initial payment, adjusted for stock splits, dividends, and the like, subject to customary closing conditions, including any required antitrust approvals applicable to the issuance of such shares. Alternatively, at our election, we may make any of these milestone payments in cash. Any such cash payment would be equal to the number of shares that would otherwise be issued for the given milestone payment (calculated as described above) multiplied by the value of our stock on the date the relevant milestone is achieved, adjusted for stock splits, dividends, and the like.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Future Products</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We plan to develop future generations of technologies focused on improved performance and convenience and that will enable intelligent insulin administration. We are also exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. We will continue to develop a networked platform with open architecture, connectivity and transmitters capable of communicating with other devices and software systems. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior. </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">III.   Supply Chain Overview</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently manufacture our products at our headquarters in San Diego, California and at our manufacturing facility in Mesa, Arizona. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;4&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manufacture our G4 PLATINUM, G5 Mobile and G6 systems with certain components supplied by outside vendors and other components that we manufacture internally. Key components that we manufacture internally include our wire-based sensors. The remaining components and assemblies are purchased from outside vendors. We then assemble, test, package and ship the finished systems, which may include a reusable transmitter, a receiver and disposable sensors. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We purchase certain components and materials used in manufacturing from single sources due to quality considerations, costs or constraints resulting from regulatory or other requirements. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthesize polymeric membranes for our sensors. For purposes of this CMR, references to our &#8220;products&#8221; refer to tangible components of our CGM systems and accessories, and references to our &#8220;suppliers&#8221; refer to our direct product suppliers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">IV.   Conflict Minerals Analysis and Reasonable Country of Origin Inquiry</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon a review of our products and our reasonable country of origin inquiry (&#8220;RCOI&#8221;), we have concluded that:</font></div><div style="line-height:120%;text-align:left;padding-left:36px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our products contain conflict minerals that are necessary to the production or functionality of such products; and</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we are unable to determine whether the conflict minerals present in our products originate in the Covered Countries.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are therefore required by the Final Rules to file with the SEC a Form SD and a Conflict Minerals Report as an exhibit thereto.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">V.   Design of Due Diligence Measures</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom designed its due diligence with respect to the source and chain of custody of the conflict minerals contained in its products based on the five-step framework set forth in the Third Edition of the Organisation for Economic Co-operation and Development&#8217;s </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">and the supplements thereto (the &#8220;OECD Guidance&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">VI.   Due Diligence Measures Performed by DexCom</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom performed the following due diligence measures in accordance with the OECD Guidance and the Final Rules:</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OECD Guidance Step #1: Establish Strong Company Management Systems</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom maintains a Conflict Minerals Policy (the &#8220;Conflict Minerals Policy&#8221;) that sets forth (i) its commitment to complying with the Final Rules, (ii) its expectations of its suppliers regarding supporting DexCom&#8217;s compliance activities, and (iii) its policies and practices with respect to the engagement of suppliers and the implementation of risk mitigation measures.  The Conflict Minerals Policy can be found on our website at https://investors.dexcom.com/corporate-governance.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The implementation of DexCom&#8217;s RCOI and the conducting of due diligence on the source and chain of custody of DexCom&#8217;s necessary conflict minerals are managed by DexCom&#8217;s supply chain, finance and legal departments.  The Audit Committee (the &#8220;Audit Committee&#8221;) of our Board of Directors (the &#8220;Board&#8221;) exercises oversight and review with respect to these processes.  To the extent that red flags or other issues are identified in the supplier data acquisition or engagement processes, these issues and red flags will be addressed first by the responsible individuals within the supply chain, finance and legal departments and </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;5&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-left:48px;text-align:left;"><font style="font-family:inherit;font-size:10pt;">then subsequently reported to and reviewed by the Audit Committee at regularly scheduled meetings of the Audit Committee on at least an annual basis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The supply chain, finance and legal staff responsible for conflict minerals compliance (i) have received training regarding conflict minerals compliance and (ii) are required to be familiar with DexCom&#8217;s Conflict Minerals Policy and with DexCom&#8217;s conflict minerals-related processes and procedures.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Records of material conflict minerals-related documentation are maintained electronically by DexCom for a period of five (5) years from the date of creation.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom&#8217;s existing suppliers have been provided with a copy of the Conflict Minerals Policy, and new suppliers will be provided with a copy of the Conflict Minerals Policy as part of DexCom&#8217;s standard supplier onboarding process.  In addition, DexCom's form manufacturing agreement contains a conflict minerals compliance provision (the &#8220;Conflict Minerals Contractual Provision&#8221;) requesting that suppliers (i) comply with the Conflict Minerals Policy and (ii) cooperate with DexCom in providing the information required by the CMRT (as defined below).  DexCom will request that the Conflict Minerals Contractual Provision be incorporated into (i) new manufacturing agreements and (ii) existing manufacturing agreements when such agreements are negotiated for renewal.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interested parties can report improper activities in violation of the Conflict Minerals Policy or the Conflict Minerals Rules via email at investor-relations@dexcom.com.  This email address is published on DexCom&#8217;s website at https://investors.dexcom.com. All reported activities will be reviewed by the appropriate individuals within the supply chain, finance and legal departments.    </font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OECD Guidance Step #2: Identify and Assess Risk in the Supply Chain</font></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom requests that its suppliers, identified as a result of DexCom&#8217;s RCOI process, complete in full the Electronic Industry Citizenship Coalition/Global e-Sustainability Initiative Conflict Minerals Reporting Template (the &#8220;CMRT&#8221;).  The CMRT is used to provide DexCom with information regarding those suppliers&#8217; practices with respect to the sourcing of conflict minerals to enable it to comply with its requirements under the Final Rules.  The CMRT will be distributed to the identified suppliers at least annually to obtain information regarding changes in supplier circumstances. </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom&#8217;s supply chain, finance and legal departments manage the collection of information reported on the CMRT by its suppliers.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom utilizes a series of escalating responses to address the failure of a supplier to provide the information required by the CMRT.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OECD Guidance Step #3: Design and Implement a Strategy to Respond to Identified Risks</font></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If, on the basis of red flags that are identified as a result of either (i) the supplier data acquisition or engagement processes or (ii) the receipt of information from other sources, DexCom determines that there is a reasonable risk that a supplier is sourcing conflict minerals that are directly or indirectly financing or benefiting armed groups, DexCom will enforce the Conflict Minerals Policy and the Conflict Minerals Contractual Provision binding such supplier (if any) by means of a series of escalations. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Such escalations may range from prompt engagement with the supplier to resolve the sourcing issue, to requiring such supplier to implement a risk management plan (which plan may involve, as appropriate, remedial action up to and including disengagement from upstream suppliers), to disengagement by DexCom from the applicable supplier.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OECD Guidance Step #4: Carry Out Independent Third-Party Audit of Supply Chain Due Diligence at Identified Points in the Supply Chain</font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;6&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Given that we do not have a direct relationship with the smelters and refiners that process the conflict minerals that are present in our products, we rely on the Responsible Minerals Initiative (the &#8220;RMI&#8221;) to conduct third-party audits of smelters and refiners.</font></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">OECD Guidance Step #5: Report on Supply Chain Due Diligence</font></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As required by the Final Rules, we have filed a Form SD and a Conflict Minerals Report as an exhibit thereto for the 2019 reporting year.  The Form SD and Conflict Minerals Report are also available on our website at https://investors.dexcom.com/sec-filings.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">VII.   Smelters and Refiners Identified</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We identified 10 suppliers who fell within the scope of our RCOI based on the type of component or part being supplied and the likelihood that the component or part contained a conflict mineral. We sent the CMRT to those 10 suppliers and received responses from all of them. DexCom&#8217;s suppliers identified the names of approximately 301 smelters and refiners from which they source conflict minerals that appear on the RMI&#8217;s Smelter Reference List (the &#8220;Smelter Reference List&#8221;), and of those smelters and refiners, approximately 267, or approximately 89%, have successfully completed an assessment against the applicable RMI Responsible Minerals Assurance Process (&#8220;RMAP&#8221;) standard or an equivalent cross-recognized standard.  With respect to those smelters and refiners appearing on the Smelter Reference List that have not successfully completed an assessment against the applicable RMAP standard or an equivalent cross-recognized assessment (the "Non-Conformant Smelters and Refiners"), although we were not able to determine the mines or locations of origin of the conflict minerals sourced from such smelters and refiners, attached as Addendum A to this CMR is a list of the country locations of such smelters and refiners as reported by our suppliers, grouped according to the specific conflict mineral processed by such smelters and refiners.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px dotted #58a618;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#58a618;font-weight:bold;">VIII.   Steps to Mitigate Risk</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom intends to take the following steps to mitigate the risk that its necessary conflict minerals benefit armed groups:</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continue to engage with suppliers to obtain complete CMRTs;</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Encourage the development of supplier capabilities to perform conflict-minerals related due diligence; and</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provide ongoing training regarding emerging best practices and other relevant topics to supply chain, finance and legal staff responsible for conflict minerals compliance.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statements relating to due diligence improvements and certain other statements herein are forward-looking in nature and are based on DexCom&#8217;s management's current expectations or beliefs. These forward-looking statements are not purely historical and reflect DexCom's or its management's intentions, beliefs, expectations and strategies for the future. These forward-looking statements fall within the meaning of the federal securities laws that relate to future events. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that could cause actual results to differ materially are more fully described under &#8220;Risk Factors&#8221; in our periodic reports filed with the SEC, including without limitation our quarterly report on Form 10-Q for the quarterly period ended March 31, 2020, as filed with the SEC on April 28, 2020.  We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results.  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;7&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DOCUMENTS INCORPORATED BY REFERENCE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless otherwise stated herein, any documents, third party materials or references to websites (including DexCom&#8217;s) are not incorporated by reference in, or considered to be a part of this CMR, unless expressly incorporated by reference herein.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;8&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Addendum A</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Non-Conformant Smelter and Refiner Country Locations by Conflict Mineral</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:75.85470085470085%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:30%;"></td><td style="width:70%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #0066cc;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Conflict Mineral</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Smelter or Refiner Country Location</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gold</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Belgium </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">China</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Czechia</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">India </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kazakhstan</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Korea (Republic of)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lithuania</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Malaysia</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mexico</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New Zealand</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Russian Federation</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Saudi Arabia</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sudan</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Turkey</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uganda</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Arab Emirates</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States of America</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uzbekistan</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Zimbabwe</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Tin</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">China</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">India</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Malaysia</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Myanmar </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vietnam</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Tungsten</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">China</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Russian Federation</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States of America</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;9&#160;&#160;&#160;&#160;</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>dexcomgreenstandalone.jpg
<TEXT>
begin 644 dexcomgreenstandalone.jpg
M_]C_X0KZ17AI9@  34T *@    @ # $   ,    ! W\   $!  ,    ! (4
M  $"  ,    $    G@$&  ,    !  4   $2  ,    !  $   $5  ,    !
M  0   $:  4    !    I@$;  4    !    K@$H  ,    !  (   $Q  (
M   D    M@$R  (    4    VH=I  0    !    \    2@ "  (  @ "  6
MXV   "<0 !;C8   )Q!!9&]B92!0:&]T;W-H;W @0T,@,C Q.2 H36%C:6YT
M;W-H*0 R,#$Y.C T.C$P(#$P.C(P.C4V      20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0   W^@ P $     0   (4         !@$#  ,
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M    %0!# &$ ;@!O &X ( !- %@ -  Y #  ( !S &4 <@!I &4 <P @ #,
M      ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4
M= !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q 8L            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ "6     0 ! )8    !  $X0DE-!"8
M  X             /X   #A"24T$#0      !    !XX0DE-!!D       0
M   >.$))30/S       )           ! #A"24TG$       "@ !
M  $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M      $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE-
M _@      '   /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z   .$))300(       0
M 0   D    )      #A"24T$'@      !      X0DE-!!H      U$    &
M              "%   #?P    X 9 !E '@ 8P!O &T +0!N &\ +0!M &$
M<@!K     0                         !              -_    A0
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    A0
M  !29VAT;&]N9P   W\    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3004       $     3A"24T$#      )B
M  $   "@    &    >   "T    );  8  '_V/_M  Q!9&]B95]#30 !_^X
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M &\ = !O ', : !O '     7 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@
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M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M_P"OOW[XW;_HZ7'_ #E?_H+KW[]WS_H\W?\ SFD_Z"Z[/9/8OT_O]O47Y/\
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M[T\^SZA'?01$C\$*&GV:P_V9Q\JYZ3__  Y=\VN/^,T_[;KCJ7_[ _Z>TO\
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M1?!H]JM;>RB(P:>+(/\ ;. G_5+CGH.>G_YFWR>ZRR\T^Y=S1=M8"MJGJ*[
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ME8YJYX9 &C^RII/HZGWC?[^\T"*VV_E*UE_5D(FGI_ I(B0_Z9@SD'(T(>#
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MD+: ?+6%KT".8/;WFWEF)KG=-J;Z('^UC(D0?-BI)0?-U7/18N+_ .W/^O\
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MZ"W77TY/'U_XW_L../>^O==WY_WUOZ_XV(/OW7NO?U_WG_B+CWK_  =>Z?\
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M0V 0K-U%?NER+:\T;+<[A:P ;]:QEHV'&15RT3>M1717X7I0@,U=6T_C^O\
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MJ=+)18O&TD;SU$I!T1H; MI!-=DV;<>8=SM-HVN R7LS4 X >99CY*HJ6/D
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M2*$,#0@@\""""#P/'J+]?]['''XY]M_X>F^NOZ?7\?T_'^O?WOKW7?\ OO\
M??3WKKW5Y7\IOY2U"5M3\8]ZY-Y:6ICK\YU-4U<S,U+40+-D-R;,B+:K4]3
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M $5A3_2*:_$137<_/^/^\\_UM^/>)GV=8G]>_P 3_CS8#W[KW7C_ *]A^?\
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MF5N7^3[F&"33?7S> E#D*P)E;[ @*U&0SJ>HP]VN9#R]RA=K!)IOKP^!'3B
MP/B,/,40$ C@S+UJL6^OXOS_ +[_ !X]X1=83]>X_P!M?C_8\?3Z>]=>Z]_O
M7/\ R/WOKW7O^17_ -]_6W^W]^Z]UL.?RA^B:?;W76Y>_,O1#^.;]KJW:VTI
MY(V#4^S<!6)'EJBFD:P(S6Z*62*0"X'\,3U79@,K_83EB.UVF]YIGC_QFZ8Q
M1&G"%#WD'^G*"#_S2%/,=96^Q7+:6>S77,L\?^-73E(SYB%#0T_TT@-?+L7/
MI<C[R#ZGKKWOW7NO>_=>Z][]U[K6E_FP]'T?77>.([.P-$E)@^Y<;69'(I3Q
MB.GCWOM]Z2EW%.!&ICC.8HJ^AJW)LTU5)4/R2Q]X=^^?+4>T\RP;S;1:;;<$
M+, ,>-'02'T[PR.?5BY]>L1O?'ER/:^8K7>K:/3;WZ$O08\:.@8^@UJ4/J6#
MGS/55GT_V_\ A_MOI;W"/4(]=?X?CZ?[;Z?7_?'WKKW7=A_L/K_A^0>??NO=
M*39N[LYL+=NV][;7K&Q^XMIYO&[@PM8M_P!C(XNKBK*4RQ@J)H&DA"R1GTR1
M%E8$$W6[??W6UW]GN5E)HNH)%D0^C*01]HQD<",>?2W;=PN=JO[/<K*31=P2
M*Z'YJ:@&E*@\&'F*@\>MT;JCL3#=M]:;'[*P17^%[UVUB\_##K61J*6MID:N
MQ=0]@IJL37K)336X\L+6]]$-BW:#?MGVS>;;$-S"K@<2I(RI^:M53\QUT'V?
M=+?>MJV[=K4_H7$*R#Y:A4@_-353\P>A#]FW1GU[W[KW7O?NO=>]^Z]T!/RC
M_P"R9?D7_P"()[=_]]_N#V&>=?\ E3>;?^E9=?\ 5B3H-<Y_\J?S7_TK;K_J
MP_6F1]!<_6W/_%/K];^^>?7/WKP ^@_'/U_XC_'WKKW77!XY/^/]+_G_ &_/
MO?7NN_\ 8_ZWT_V%O?NO=;.G\IFAHJ;XI)64U'305>2[%W=+D*F*"..HKI:=
M,72T\E7,JJ\[4]+$L:%R=** /Z>\S?8J*-.1Q(D:AWNY=1  )II )/G0 #[.
M'69/LE%$G(T#I& [W,I8TRQ#  D^9   )X #JSGW,O4O=>]^Z]U[W[KW56?\
MWB.)OBSA6=$=H>W]I20EU4F*0[<WG 9(R1=',,S+<6]+$?0D&$_?M0W)-L2.
M&X1$?+].;A^1(^ROSZAOWS53R2A*@LM[$1\CID%1Z&A(^PT\^M9[G_>_Z<?[
MQ[PY^?6'G77'U_QXM8_CZ^_=>Z]_3@?ZU_SR/\![]U[KL_3_ 'G_ &WOW7NM
MT+XWXW'XCX^](4&+HZ;'T:=3]?S)24D,=/#Y:O:V+JZN<I&B@S5=74/+*_+2
M2NSL2S$GH?RA#%!RIRU%#&$B%A!@"@J8E)/VDDDGB222:GKH3RQ%%!RWL$,$
M86,6<- !09C4G]IR?4U.37H:_8CZ/NO>_=>Z][]U[K7E_G,*H[7Z>< !VZ]R
MRLU@&94W)4%06-BRJTAL#P+G^I]XH?>% &^<OGS^D;_JX?\ 9_GUBW]X$#]Z
M\NFF?IY/^/CJFP7YO?\ WW]![Q[ZQ\Z]Q_A?_B+G_;>_=>ZZ_'TN;_[[_8<>
M]]>Z]P?]8?XV/^WO^??NO=?_U!+_ ,3_ +SP.?Z_XV]\S>N;/7O\;_T%C[]3
MK77O]\/H/I>W!_P]^Z]UUQ_6W^!/^-[6O;@>_=>ZNT_DO&^[N^__  W-B'Z_
M]7+<G^^_I[R.^[Q_N?S1_P T8?\ CTG61GW?/]RN:/\ FG!_AEZOZ]Y2=9-]
M>]^Z]U[W[KW7O?NO=:XW\X78*X+O#8._Z>F,%/V!L1\?5RZ;1U>;V3DWIJJ8
M26 :5,+G<:C#^RJ*?S[Q&]_]K^EYEVO=56B75KI)]7A:A/\ O#QBGR'KUBA[
M^;8+?F#:=T44%S;%#\VA;C]NF11\J#JHNW_$_P"^_K?GW W4#]>L+?\ $<?X
M_C_7/OW7NNA_MO\ #\C\C^O/OW7NO#GD_P"V_IS_ %'O77NMFS^4MOV3=7QA
MJ-JU50\M5UMOS<&!IHI#J>+"9J.CW50E269O"^1S%:BCBWBL.![S*]B=T-[R
M8]B[U>SNG0#^@])1_P :=P/LZS&]D=S-]R6+-V)>TN9(\_PM25?RJ[ ?93AU
M:%[FGJ8>O>_=>Z][]U[K3M^9N_6[*^4?=NZ?.U12_P!^LGM[&2V8(^(V;X]H
MXJ6%6 ,<4]#A$E (#'620&)'OG_[A[I^^.=>9+T/J3ZIHU/JD5(E(]*A ?SS
MGK SW$W,[OSKS%=:B4%RT:_Z6&D0I\CHU?G6E2>BQV(/'_&K>P;T"^N^1]>?
MZ6_P_KS;W[KW7N ?]A_Q/XXYY]^Z]U8U_*NVS'GOE]MG(R1B0;/VAO;<J:]3
M*DDN(.UXY-(1UU(VY;J6TA38@Z@ 9;]DK,77/UG*17Z>WFD_,IX?_63_ %&G
M4N>R=FESSU;S,M?I[:60?:0(O^LA_P"+QUM)^\U^LR^O>_=>Z][]U[KWOW7N
MH]554]%!/5U<\--2TL$U54U-3*D%/3T\"&2>>>>0K'###&"S,QL "20![H[I
M$CR2.%C4$DDT  R22> 'F>JLRHK.[ (!4DX  \SUI/=O[R3L7M?LW?\ "K+#
MO?L#>.[*=#Y5,5-N'<&0RM+"$G+RQI!!5*BJQNJ@#\>^<N_;@-VWW>=T [;F
MZEE S@22,P&?0&F?LZYY<P;@N[;]O.Z(24N+J61:U^%W9E%#D4!  / 8Z#NU
M_K_Q%C_M[^RKHGZ]]/\ ?6^@_I]/>OMZ]U[_ 'W _P ?]C]/>_EU[K;F_E^U
MM1D/AUT7/4MJDCVUE*)2-7$&-W5G\=2KZF8G12TJ#ZVXX ' SQ]JY&E]ON6F
M?XO!9?R65U'\@.L[?;.1I>1.66?B+>GY*[*/Y ='']R#T.NO>_=>Z][]U[KW
MOW7NM>7^9'\%'V+79;Y!=/X9CLG*53UO8NU,92W79^3JVDDGW1BJ.GB"T^TJ
MZ4_Y5$.,?4/J4?;2::?$_P!W_;,[7+/S7L%O_NM=JSQ*/[)CQD4 8B8_$/P,
M<=C43%OW=]MC8R3\U;!;?XBQ+7$:C^S8Y,J@?Z&?QC\!.KX"=%-G^]V_WKZ?
MZW^W]X^]8^=>_P!AQ:_^//OW7NO'^O\ Q-C_ (7^G'OW7NC ?'+Y)=D?&;?4
M&\]@Y M1U+TU/NK:E8[G ;NQ,$Q9L?DX0&\-3$LCFEK(P)Z5V)4E6DC<4<I<
MW[OR;NB[CM<WZ;4$L1^"5 ?A8>HSI8=RDFF"017RCSANW)VY+?[;)6%J"6(G
MLE4>1XT(J2KC*GU!*FUKY$_S:<7E^M,9A_C[C<UA-^;JQ(;<N=W%1Q*W79F6
M>GJ\;A '>FS6?+J'@K0II8(&5M!G+1T\Y<V>^L%QLT-ORK#)'NDZ?J/(!^A6
MH*IY/)YAZ:0I!H6)"S=S7[XVLNSPP\JQ2)NDZ=[R+_85J"%XAY/X6%4 H34U
M446UE95Y"KJLA7U516UU=//65M;63R5-55U=3*TU35U53,SRU%142N7=V8N[
M$DDDD^\9Y)))G>65RTC,2234DDU)).22<DGCUC5+))-))--(SRN269B223DD
MDY)/$DY)SU&_V/\ K6 _'_$ ^Z=-]=V_WW^M_A_7WOKW2FV;L[<_8.Z<%LK9
MF&J]P[IW)D(<7AL/0H'J:RKFN;7<K%!3PQ(TLTTK+%#"C22,J*S!9M^WWNZ7
MMMMVWVS2WLS!41>))_D !4DD@**DD $A;MVW7F[7UMMNW6[2WTS:44<2?\
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M_??X6_K[]U[KKZ_C_;_['WKKW7N/I_O%O]C_ *UP?>^O=;J7Q_\ ^9#])_\
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MVQL:R1BI,!/F/6(G@>*<#BAZJH_WUK?C_'CZV]PAU"'7C]/ZCZ&Q_H;WYO\
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M9B2;W)//OF^2222<_P ^N=#,78LS$L<DG)/S/K7S_;UPM_QHG^O'OW6NN_\
MBG^''^/^O[]U[KW'/'];\?[[Z^_=>Z.9_+WVXNZ/F/TA02P^6&@SV8W&Y:)G
MCA?:VU,]N.DE=@KB.U?C(0C&P$C+R#;W(?M39B]]P.6XF%565Y/L\*)Y ?EW
M**?.G4A^U-K]7S_R\A2J([N<5IHBD8$^G<%H?4CSZVX?>=_6<G7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:<'R^W:^^/D_W
MON%IC41R=E[GQ%'.5D0R8O;.0DVSB'T2:9$!QF'ALI"L!P0/I[Y]<^WS;ESI
MS/=EJCZR50?58V,:<>':@ZP(Y_O_ -Y<Z<S7-<?5N@/RB/A+_)!_F\NBX_C_
M %O\/I;_ %S_ %]A+H']>)_P^@_J.+_[U[UU[KW/^M^3_O5K?ZP][Z]TKNO\
M(-S;\V3MQH_*NX-W;;P9B)0"1<MFJ*@*'R@Q@,*BWJ!7GGB_M=M5L+S<]NLR
M,2W$:?;J<+]GGY]&6S6PO=XVJT8566YB2F,AG5?/[>MW_P!]).NBO7O?NO=>
M]^Z]U[W[KW7O?NO=%&^>.&7._$+OBB<(RP;,.:"R6 U[;R^+W#&061QK5\6"
MO%RUK$?4 /W/MA=<@\SQD8%OK_YQNL@_X[_LCH$^X]NMSR-S-&PJ!:L^?^%D
M./V%<=:A?^^X%^>0?ZFWO GK [KWU/\ B/\ 8CGZ_3_6]^Z]U[\\_GZ?[W_K
M7]ZZ]U[_ %[?G_BGY_'O?7NK>?Y.>[),=WGV5LYI=%+NCK(YA8K-_E&3VIN/
M$14:>FZJR8_<5:P+6%@1<$@&>ON_7QBYEW?;BWZ<]EK^UHI$ _XS(_4]>P5\
M8N8=YVZO;-:!_P XI% '[)6_U<=C3WEQUE;U[W[KW7O?NO=>]^Z]T!/RC_[)
ME^17_B">W/\ WW^X/89YU_Y4WFW_ *5EU_U8DZ#7.?\ RI_-?_2MNO\ JP_6
MF1_CS_ON?QP/?//KG[UT/K_OK#_B3<>_=>Z]S^+V^GT_UO\ #W[KW7=OZ?['
M_?'W[KW6T!_*>_[)(Q_U_P"9@[U^O_+7'?XGWFA[&?\ *B1?\]4W^%>LS?93
M_E0[3_GHF_X_U9;[F+J6NO>_=>Z][]U[JKC^;M_V2QB?_$N;1_\ =#O#W"GO
MU_RI-O\ \]\7_')>H<]\O^5('_/9%_@?K69_Q_XG_;_X>\..L.^O?U_VW]+_
M ->>3;WKKW7O\/\ ;_['Z?U/O?7NO?C\W_XI_O9]^XXZ]UNH_'__ )D/TG_X
MB/K?_P!XW#>^BG*O_*K\M_\ /!;_ /5I.NAW+O\ RK^Q?\\</_5M>A<]GW1S
MU[W[KW7O?NO=:\_\Y@?\95Z</_?OLO\ ^]'-[Q1^\+_R6^7_ /GE?_JX>L7/
MO _\E7ES_GGD_P"/CJFD?X?7^MK'\@'GWCWUCWUW?_ 6_K_O9_VWOW7NNO\
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M+F><6W+?,-R2:1V-PV./;$YQPSC'S\^M+7_8_P!?Z?U^H^OY]\[.N>O71O\
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M;H-423.U:4KJ8GAY<>'3+^?P/Z?UX_V'T'M/TDZ]S_KC_D7^WM[UU[KW]?\
M>1]?]C_L1[WU[H<OC!1QUWR4^/M'+ M5!4=V]515%.4\B2TQWS@ON5E0 ZHO
MM@VN_ 2_XO[$O)B"7G#E2-EU*=RMJCY>,E?RIQZ$O)D?B<W\K)HU [C;5''
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M_K>]];Z__]<2[_[S_@?]A[YF]<V.O?X?G_'G_8\F_/OW6^O'\?T_H/\ ;_\
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MO_.)R@IOCCL3%K)(DV3[FPL[(JWCEH\=LS?)G61K@#35U5.RCZG3_@?<$_>
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ML^Z.>O>_=>Z][]U[K7G_ )S/_,U>G!?_ )I]F+#D?\Q'-_3WBC]X7_DM\O\
M_/(__5P]8N?>!_Y*G+O_ #SR?\?7JFG_ & _P^G^O_O'O'OK'O'7?^OR/]X_
MV'/'OW7NNAS_ ,:O^+?4$<>]=>Z[_P /S;Z_ZY_V'O?7NO_2$JQ^G^M_L>/^
M*^^9G7-CKP_V)_QN?]Z^@X][Z]UW;_'Z<\?G^O YO[]U[KW!_P!O_L1_Q-_?
MNO=79_R7?^/M[[_I_=S8EO\ SY[E_'];>\CON[_[G\T?\T8?^/2=9&?=\_W*
MYI_YIP?X9>K^O>4G63?7O?NO=>]^Z]U[W[KW6K3_ #1^RX.P/E7GL-05*56,
MZQV]A=@Q/"286R<'W.X-P7!"G[BDS&=EHY?KZJ2W(M[PG]ZMY7=>>+N")ZPV
M420 CAJ%9'_,.Y0_-/EUAG[T[PNY\YS6L3UALH4A^6O,C_F"^@_->JYP?\#S
M_MOI8?[#W$O42=>'^OS_ ,0;?X>_=>Z[_P!?Z?3\D^_=>ZZX/]/S^>+_ (_K
M?W[KW6V5_+GZVDZT^)?6E/64[4^7WK%D.QLHK(4:0;LJ?N,'*RD!@S;3@QP-
M^=0/XM;.CVDV=MGY#V8.E)KD-<-\_%-4/_.(1_X.LX_:O:#L_(^S12+2>=3.
MWE_:G4O[(] /S'1Y/<E=2)U[W[KW7O?NO=:<7R^V&W6WR=[NVG]M]G34^_\
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MY1Y=W'7J=[5 QX]Z#PY/^-JW70+D_<QO/*VP[D&J\MLFH\>]1I?]CJP_P]&
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MD^>A?TT_FK,/DU>K1?<T]3%U[W[KW7O?NO=>]^Z]T!/RC_[)E^17_B">W/\
MWW^X/89YU_Y4WFW_ *5EU_U8DZ#7.?\ RI_-?_2MNO\ JP_6F/QQ_7ZBQ^H)
M_P!@#[YY\.N?O7?TXL?\".?^-_CW[KW77X%N/];_ !_'!^GOW7NO<_3\?[XC
MW[KW6T#_ "GO^R2:#_Q(.]?^MN/'O-#V,_Y42+_GKF_PKUF=[*?\J':?\]$W
M_'^K+?<Q=2SU[W[KW7O?NO=5<?S=O^R5\3_XES:7_N@WA_O?N%/?K_E2;?\
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MF0O<2NSLQXLS$LQ/S))/Y]8#75S/>7-Q>7+EKB61G=CYLQ)8_F23TV'\&_\
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M[\H>Y?D"^V-N5JUVT>GZ*IV?15,$HFI*_=%15)4[RR-(RG3XDK((,>6%U?\
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MZ?F__&A^#]/?NO=7:?R7O^/N[Z_\-S8O_NSW)_O/O(W[N_\ N?S1_P T8?\
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M4@<?&+8>395"T>4[;R%#,07$BQUF%V-Y8VOHT-'7Y!0.;TT6KBH0XR>^//3
MCDS:YZ8#73 \?-(?\#R>O8M?B'6-_O;SP4 Y.VR:C$!KEE/D<K#CUP[CTT#(
M+#JBD?\ %/\ ??C^OO&CK&CKO_??XWM?_>O>NO=>_P!?_B?]\?>^O=/NV-M9
MS>>XL'M/;&-J<SN+<F5H<+A,52+JJ:_)Y*HCIJ2FC#%45GED U,55!ZF(4$A
M396=UN%W;6%E TEW,X1%'%F8T _,GSQZD=*K*RN=RO+6PLH3)=S.$11Q+,:
M?+[3@#)P*];=7Q(^,^WOB_U1C-ET7VU?NW)_;YC?^Y8(RK9W<;P@2Q4\DBK,
M,+A4D--1(VG]H-(566:6^>?(?)MIR5L4.WQ:6OI*//(/QR4X#ST(.U!C U$:
MF;K.WDCE&TY.V.#;8:-=M1II*?')3/\ M5^%!Z9XD]&F]C;H8=>]^Z]U[W[K
MW5%O\T_X>HT57\GNNL6J2(:>#MW"T,0"RHVBEH=_00H% E5O'394+?4&BJ2M
MQ52G&?WM]OUTOSIM$.<"Z11^2S@?L62G]%R/[1CCC[T\A"1).<=JA_46@ND
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MGKWJMYK:?:N4"^IP5:Y(*T'GX2FC5(_&P4K^$$T84:$W)9N2Q-R?J2?J3?\
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M_P /?NO=>_J/]<_\3[]U[KU[#_6_XBW_ !'OW7NMH#^4]_V23C__ !(.]/\
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M1_Q(_'^V]^Z]U[_??3^O_&_?NO=7/?R_?Y>63W3DL#WAWS@)*+9M']OE]D;
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MWU]@'H =>O\ CZ<V_K?_ (US[]U[KH?3_7^G^/\ 3C^@]ZZ]U[Z?[#_7^O\
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M]_QJ_P#R+_'WX=>Z]_O7^Q/_ "/WKK?7N/R>?]M^>./\#[WUKKK_ 'PYX_'
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M24WGLG:G8FVLIL_>^ QFYMM9J#[;)X;+P"JHJF/4LBG2=+Q3P2('BEC*RPN
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M]V<]_#?[S?WW\7\,M1?QG^&?WF_R#^)_8W_3^]]KY[<:O8Y]O?\ 6E_K$O\
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M_P"Q.7_?QO\ V+/^']>/?O\ P'[_ )?/^SKK7_@/_P#R\?\ 9YU[_L3E8_\
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MNO>_=>Z#OM[^YO\ HG[0_P!(OW7^C[_1WO3^_?V7WGW?]S?[MY/^\_VG\/\
M\N^Y_@GGT>#][5;1ZK>RG?\ ]W_N+>OWMJ_=7TDWC4K7PO#;Q*:>ZNC52F?3
M-.BO?/W?^Y-X_>U?W5]++XU-5?"\-O$II[JZ*TTY],]43?\ 8G'_ +^+^/\
MG[/]?\/\?>,O_@/W_+W_ -G76-__ (#_ /\ +Q_V>=>_[$Y?C_2+_L/]+'OW
M_@/W_+Y_V==;_P# ?_\ EX_[/.O?]B<OS_I&_/U_TL_['_8?\1[]_P" _?\
M+Y_V==:_\!__ .7C_L\Z[/\ PSE?_FHU['Z?Z6/\/Z^_?^ _?\O?_9UUO_F
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M;Z?]_9]^_P# ?O\ E[_[.NM_\P _Y>/^SSKK_L3C_P!_&^O_ ']FW^/^PO\
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BR_[^-^/^?LV_V%_?O_ ?O^7O_LYZU_X#_P#\O'_9YU__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
